Searchable abstracts of presentations at key conferences in endocrinology

ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Endocrine Abstracts

Published by BioScientifica

Previous issue | Volume 35 | ECE2014 | Next issue

16th European Congress of Endocrinology

Poster Presentations

Thyroid Cancer

Previous section
Thyroid (non-cancer)

Table of contents

ea0035p1083 | Thyroid Cancer

Langerhans cell histiocytosis and papillary thyroid carcinoma

ea0035p1084 | Thyroid Cancer

Thyroid carcinoma in cases with end stage renal disease

ea0035p1085 | Thyroid Cancer

The deleterious effect of levothyroxine (T₄) withdrawal on the degree of lipid profile change during follow-up of patients with differentiated thyroid cancer (DTC)

ea0035p1086 | Thyroid Cancer

Symptomatic hypercalcemia due to primary hyperparathyroidism by parathyroid carcinoma

ea0035p1087 | Thyroid Cancer

Incidence of thyroid microcarcinoma in relation to gender and age in non-toxic thyroid diseases treated with total thyroidectomy

ea0035p1088 | Thyroid Cancer

Estimated 10-year risk of bone fracture in women with diffentiated thyroid cancer on TSH-suppressive levo-thyroxine therapy

ea0035p1089 | Thyroid Cancer

Prognosis and outcome analysis of thyroid cancer: experience from a tertiary care centre in Pakistan

ea0035p1090 | Thyroid Cancer

Sentinel lymph node biopsy in thyroid papillary and medullary microcarcinomas

ea0035p1091 | Thyroid Cancer

Surgical treatment of papillary thyroid carcinoma in children and adolescents

ea0035p1092 | Thyroid Cancer

Correlation between biochemical and ultrasound parameters in patients with single parathyroid adenoma

ea0035p1093 | Thyroid Cancer

Atorvastatin medullar thyroid cancer over TT cell line impact of apoptosis and calcitonin over gene expression

ea0035p1094 | Thyroid Cancer

Anti-proliferative effects of evodiamine on human thyroid cancer cells

ea0035p1095 | Thyroid Cancer

Differential miRNAs expression in papillary thyroid cancer is associated with clinico-pathological features and BRAF mutation

ea0035p1096 | Thyroid Cancer

Ultrasound risk factors of thyroid cancer

ea0035p1097 | Thyroid Cancer

Do the poorly differentiated and undifferentiated thyroid carcinomas could be the next candidates to somatostatin analoques treatment?

ea0035p1098 | Thyroid Cancer

Risk factors of cancer relapse in differentiated thyroid carcinomas

ea0035p1099 | Thyroid Cancer

DNMT1 expression in papillary thyroid carcinoma

ea0035p1100 | Thyroid Cancer

Methylation status of HOXB4 gene in papillary thyroid carcinoma

ea0035p1101 | Thyroid Cancer

The influence of polymorphisms in tumor suppressor genes in thyroid carcinomas

ea0035p1102 | Thyroid Cancer

Familial medullary thyroid carcinomas: RET mutation in exon 8 is associated with better prognosis but increased risk for other malignancies

ea0035p1103 | Thyroid Cancer

Single nucleotide polymorphisms associated with papillary thyroid cancer

ea0035p1104 | Thyroid Cancer

A retrospective gender-comparative evaluation of differentiated thyroid cancers

ea0035p1105 | Thyroid Cancer

Nonincidentally and incidentally discovered thyroid cancer

ea0035p1106 | Thyroid Cancer

The role of DNA repair proteins in the assessment of thyroid nodules

ea0035p1107 | Thyroid Cancer

Effects of zoledronic acid monohydrate on cytotoxicity and apoptosis in BCPAP human papillary thyroid carcinoma cell line

ea0035p1108 | Thyroid Cancer

Morphology of recurrent papillary thyroid carcinoma

ea0035p1109 | Thyroid Cancer

Ca 19-9: is there a role for potential new biomarker for medullary thyroid cancer?

ea0035p1110 | Thyroid Cancer

Metastatic thyroid papillary microcarcinomas

ea0035p1111 | Thyroid Cancer

Prognostic implications of stage pT3 in well differentiated thyroid cancer

ea0035p1112 | Thyroid Cancer

The utility of ultrasonographic features on the accuracy of diagnosing individual types of thyroid malignancies

ea0035p1113 | Thyroid Cancer

Prognosis of papillary and follicular thyroid cancers with serum thyroglobulin antibody at 1 year after total thyroidectomy

ea0035p1114 | Thyroid Cancer

Increased mean platelet volume in papillary thyroid cancer

ea0035p1115 | Thyroid Cancer

Preoperative TSH value, does it predict the surgical findings in papillary thyroid cancer?

ea0035p1116 | Thyroid Cancer

Thyroglobulin measurements in fine-needle aspiration cytology of lymph nodes in patients after thyroidectomy because of differentiated thyroid cancer

ea0035p1117 | Thyroid Cancer

Prediction of lymph node metastasis in papillary thyroid cancer by preoperative BRAF analysis, is it useful?

ea0035p1118 | Thyroid Cancer

Clinical and biochemical characteristics of papillary thyroid cancer according to the presence of BRAF (V600E) mutation

ea0035p1119 | Thyroid Cancer

Survivin splice variants expression in thyroid malignancy

ea0035p1120 | Thyroid Cancer

Diffuse sclerosing variant of papillary thyroid carcinoma is a rare variant

ea0035p1121 | Thyroid Cancer

The role of microRNAs in regulation of RARβ and its function in development of papillary thyroid carcinoma

ea0035p1122 | Thyroid Cancer

Rising serum thyroglobulin in the follow-up of patients with differentiated thyroid carcinoma: the role of FDG PET–CT

ea0035p1123 | Thyroid Cancer

Sodium–iodide symporter and its microRNA-dependent deregulation in papillary thyroid carcinoma.

ea0035p1124 | Thyroid Cancer

Functional analysis of newly discovered microRNA deregulated in papillary thyroid carcinoma

ea0035p1125 | Thyroid Cancer

Apical iodide transporter and its microRNA-induced silencing in thyroid malignancies

ea0035p1126 | Thyroid Cancer

TERT promoter mutations correlate with a more advanced stage at diagnosis and with a poorer prognosis in differentiated thyroid cancer

ea0035p1127 | Thyroid Cancer

Abstract unavailable

ea0035p1128 | Thyroid Cancer

Next-generation sequencing reveals a novel thyroglobulin-embedded microRNA gene deregulated in papillary thyroid carcinoma

ea0035p1129 | Thyroid Cancer

The role of ATM–CHEK2–BRCA1 axis in determination of genetic predisposition and clinical presentation of papillary thyroid carcinoma

ea0035p1130 | Thyroid Cancer

Evaluation of factors predict the efficacy of thyroid remnant ablation in patients with differentiated thyroid carcinoma

ea0035p1131 | Thyroid Cancer

The role of the transcription factor: Prospero homeobox 1: in the biology of differentiated thyroid cancer

ea0035p1132 | Thyroid Cancer

Treatment outcomes and prognosis of medullary thyroid carcinoma in a tertiary endocrinology center

ea0035p1133 | Thyroid Cancer

The presence of BRAF^V600E mutation in patients diagnosed of papillary thyroid carcinoma in holycross cancer centre in Kielce, Poland

ea0035p1134 | Thyroid Cancer

Papillary thyroid microcarcinoma: focus on prevalence, characterization and follow-up during a 10 years time period

ea0035p1135 | Thyroid Cancer

The role of podoplanin in the biology of differentiated thyroid cancers

ea0035p1136 | Thyroid Cancer

Prevalence and risk of malignancy of thyroid incidentalomas discovered by ¹⁸F-fluorodeoxyglucose positron emission tomography

ea0035p1137 | Thyroid Cancer

Gardner syndrome; a case of presenting with agressive varyant papillary thyroide cancer

ea0035p1138 | Thyroid Cancer

Prognostic factors in 213 patients with differentiated thyroid cancer

ea0035p1139 | Thyroid Cancer

The effect of allelic variants of the thyroid hormone receptor β (THRB) gene on the incidence of papillary thyroid carcinoma

ea0035p1140 | Thyroid Cancer

Thyroglobulin before radio remnant ablation during levothyroxine withdrawal can be considered an accurate parameter of remission of differentiated thyroid cancer

ea0035p1141 | Thyroid Cancer

The usefulness of thyroid function tests for the estimation of individual sensitivity to levothyroxine therapy in patients with thyroid cancer

ea0035p1142 | Thyroid Cancer

Polymorphic pre-miR-146a and synergistic action of all of its products on NTRK2 gene in papillary thyroid carcinoma

ea0035p1143 | Thyroid Cancer

Post-ablative thyroglobulin level as a predictor of favourable prognosis in patients with differentiated thyroid cancer

ea0035p1144 | Thyroid Cancer

Coexistence of mutations in the CHEK2 and BRAF^V600E genes and their impact on the course of the papillary thyroid carcinoma (PTC)

ea0035p1145 | Thyroid Cancer

Impact of different methods on the detection frequency of BRAF mutation in papillary thyroid carcinoma

ea0035p1146 | Thyroid Cancer

Long-term follow-up of young patients submitted to radiotherapy: analysis of ten thyroid cancer cases

ea0035p1147 | Thyroid Cancer

Occurrence other than V600E mutation in the BRAF gene in papillary thyroid carcinoma

ea0035p1148 | Thyroid Cancer

Does lymphocytic thyroiditis influence the histological characteristics and the course of thyroid carcinoma in children and adolescents?

ea0035p1149 | Thyroid Cancer

Prognostic significance of TERT promoter mutations in follicular cell-derived thyroid carcinomas

ea0035p1150 | Thyroid Cancer

BRAF V600E genetic mutation analysis in patients had been diagnosed of unknown malignancy potential thyroid tumors and papillary thyroid microcarcinoma

ea0035p1151 | Thyroid Cancer

Prognosis of papillary thyroid cancer with lung metastasis at diagnosis

ea0035p1152 | Thyroid Cancer

Gene expression signature associated with BRAFV600E mutation in human papillary thyroid carcinoma based on transgenic mouse model

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

Biosci Abstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more